Algorae Pharmaceuticals
(OTC) LVCLF
Algorae Pharmaceuticals Financials at a Glance
Market Cap
$13.56M
Revenue (TTM)
$125.20K
Net Income (TTM)
$2.31M
EPS (TTM)
$-0.00
P/E Ratio
-19.75
Dividend
$0.00
Beta (Volatility)
0.51 (Low)
Dividend
$0.00
Beta (Volatility)
0.51 (Low)
Price
$0.01
Volume
1,990,000
Open
$0.01
Price
$0.01
Volume
1,990,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
0.51 (Low)
Price
$0.01
Volume
1,990,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.01
LVCLF News
LVCLF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Algorae Pharmaceuticals
Industry
Biotechnology
Sector
Health CareCEO
Bernard E. Tuch, PhD
Website
www.algoraepharma.comHeadquarters
Melbourne, NSW 2000, AU
LVCLF Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-17%
Net Income Margin
-17%
Return on Equity
-48%
Return on Capital
-69%
Return on Assets
-66%
Earnings Yield
-5.06%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$13.56M
Shares Outstanding
1.72B
Volume
1.99M
Short Interest
0.00%
Avg. Volume
32.62K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$1.56M
EBITDA
$0.00
Operating Cash Flow
$785.00
Capital Expenditure
$0.00
Free Cash Flow
$785.00
Cash & ST Invst.
$2.32M
Total Debt
$0.00
Algorae Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$13.56M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$863.57K
+40.5%
EBITDA
$1.16M
-101.1%
Quarterly Fundamentals
Net Cash
$1.88M
-48.0%
Accounts Receivable
$28.11K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-65.64%
N/A
Return on Invested Capital
-68.93%
N/A
Free Cash Flow
$617.97K
+38.7%
Operating Cash Flow
$617.96K
+38.7%